Product Information
BUDESONIDE EC 3 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.4975 per EA under NDC 65162077810. Its NADAC has been published 452 times since Feb 7, 2018.
FDA first approved this application on Jul 31, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162077810
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206200FDA Approved
7/31/2017
TE Code
AB
On Market Since
9/15/2017
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE EC 3 MG CAPSULE has been published 452 times since Feb 7, 2018, and over the history we have for it it has declined 89.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4975 per EA |
|---|---|
| All-time high | $5.3364 (Mar 14, 2018) |
| All-time low | $0.4242 (Nov 20, 2024) |
| 52-week high | $0.5230 |
| 52-week low | $0.4975 |
| Median price | $0.8379 |
| Average price | $1.2153 |
| Largest weekly change | -35.6% (Apr 22, 2020) |
| Weeks tracked | 452 |
| Tracking since | Feb 7, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Budesonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUDESONIDE EC 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE EC 3 MG CAPSULE, manufactured by Amneal Pharmaceuticals LLC, is $0.4975 per EA (NDC 65162077810), effective Sep 30, 2026.
How has the price of BUDESONIDE EC 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUDESONIDE EC 3 MG CAPSULE has declined 89.8%. It has been tracked across 452 weekly CMS publications since Feb 7, 2018.
What are the highest and lowest recorded NADAC prices for BUDESONIDE EC 3 MG CAPSULE?
Since Feb 7, 2018, the NADAC for BUDESONIDE EC 3 MG CAPSULE has ranged from a low of $0.4242 (Nov 20, 2024) to a high of $5.3364 (Mar 14, 2018), with a median of $0.8379 per EA.
Are there cheaper alternatives to BUDESONIDE EC 3 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUDESONIDE EC 3 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BUDESONIDE EC 3 MG CAPSULE?
BUDESONIDE EC 3 MG CAPSULE (NDC 65162077810) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.